A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

Clinical trial NCT05154240 · COMPLETED

Trial details

NCT number: NCT05154240
Sponsor: InSilico Medicine Hong Kong Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2022-02-21
Primary completion: 2022-12-02
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.